MedPath

Feasibility, Safety and QoL After Merendino Procedure

Completed
Conditions
Benign or Early Malignant Lesion of the Distal Esophagus or Gastro-esophageal Junction Requiring Surgical Resection
Interventions
Other: EORTC and QLQ-C30 / QLQ-OES24 questionnaire
Registration Number
NCT02855333
Lead Sponsor
Kantonsspital Liestal
Brief Summary

The purpose of this study is to analyse retrospectively the early postoperative and functional outcome of patients (pts) after Merendino procedure for benign or early malignant lesions of the distal part of the esophagus or the gastroesophageal junction.

Detailed Description

Between 2004 and 2013, 14 pts had transhiatal resection of median 8 (6-10) cm of distal esophagus including the gastroesophageal junction. Locoregional lymphadenectomy was performed in all patients with (suspected) early adenocarcinoma. In case of vagus nerve resection, pyloromyectomy and cholecystectomy were done. A pediculated isoperistaltic jejunal segment of 15-18 cm length was interponed between esophageal stump and remaining stomach by end-to-side anastomoses. At least one postoperative contrast examination of the anastomoses was done in all pts. Quality of life was assessed by using the EORTC QLQ-OES18 survey, recording patients' general activity and condition and specific gastrointestinal symptoms.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
26
Inclusion Criteria
  • alive
  • MER or CON procedure
  • informed consent
  • CON patients were matched according to diagnosis, Age and ASA score
Exclusion Criteria
  • withdrawal of informed consent
  • legal incapacity
  • limitations in mental state or medical condition precluding questioning (only QoL data)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Merendino Group (MER)EORTC and QLQ-C30 / QLQ-OES24 questionnairePatients who underwent merendino procedure for benign or early malignant lesions of the distal esophagus/gastroesophageal junction Perioperative data and EORTC and QLQ-C30 / QLQ-OES24 questionnaire
Control Group (CON)EORTC and QLQ-C30 / QLQ-OES24 questionnairePatients who underwent alternative surgery for benign or early malignant lesions of the distal esophagus/gastroesophageal junction Perioperative data and EORTC and QLQ-C30 / QLQ-OES24 questionnaire
Primary Outcome Measures
NameTimeMethod
Quality of Life (QoL)up to 10 years after surgery

EORTC QLQ-C30 and QLQ-OES24 questionnaire (global health status item, functional and symptom scale items)

Secondary Outcome Measures
NameTimeMethod
Intraoperative complicationsup to 1 day after surgery

Blood loss (ml), requirement for blood transfusion (units), operation time (min)

Postoperative complicationsup to 100 days after surgery

Morbidity (re-intervention rate, re-operation rate), in-hospital mortality

Trial Locations

Locations (1)

Kantonsspital Baselland, Liestal

🇨🇭

Liestal, Basel-Land, Switzerland

© Copyright 2025. All Rights Reserved by MedPath